Target intelligence / Profile preview

WW domain binding protein 1-like pseudogene 2 (WBP1LP2)

Target: WBP1LP2
Molecular classification: Other (pseudogene)

Overview

WW domain binding protein 1-like pseudogene 2 (WBP1LP2) is a non-functional DNA sequence similar to the WBP1L gene, which encodes a transmembrane adaptor protein involved in hematopoiesis and the regulation of CXCR4 signaling[1][2][4][5]. Unlike the protein-coding WBP1L gene, WBP1LP2 does not encode a functional protein and is therefore not implicated in disease processes or therapeutic strategies. Pseudogenes are typically regarded as genomic 'fossils' and are not drug targets or biomarkers in clinical practice. Note: If you are interested in the functional protein-coding gene, consult entries for WW domain binding protein 1-like (WBP1L, also known as OPAL1), which is a transmembrane adaptor protein with roles in hematopoiesis, stem cell function, and leukemia prognosis[1][2][4][5]. The pseudogene (WBP1LP2) itself does not share these properties.

Other names: WW domain binding protein 1-like pseudogene 2WBP1LP2

Mechanism of action

None. Mechanisms of action described in the literature pertain to the encoded WBP1L protein, not its pseudogene

Biological functions

Pseudogenes generally lack direct biological functions, though emerging research suggests some may have regulatory roles. For WBP1L pseudogene 2, there is no evidence supporting a functional biological role

Disease associations

None reported for the pseudogene. Studies discuss disease roles for WBP1L protein such as in leukemia, but not for this pseudogene

Safety considerations

None. There are no safety concerns or therapeutic challenges associated with the pseudogene, as it is not a functional drug target

Interacting drugs

None. There are no drugs known to interact with this pseudogene

Biomarkers

None reported for the pseudogene. WBP1L itself may have relevance as a biomarker for leukemia prognosis, but not its pseudogene

Beyond the preview

Go deeper on WW domain binding protein 1-like pseudogene 2 (WBP1LP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WW domain binding protein 1-like pseudogene 2 (WBP1LP2).

Explore the full profile